The harms driven by synthetic drug markets, including overdoses, chronic and severe mental health conditions, and community fragmentation, are escalating, the report notes.
Background Data-sharing mandates from funders and journals have increased in recent years, but little is known about how shared data are used. Existing research has focused on access frameworks, with ...
With deep expertise backed by $270 billion in valuations, Eqvista Real-Time Company Valuation® platform is set to value ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results